[1]
F. Mehmood, M. Zeeshan, M. Umair, N. Khan, A. Wajid, and A. Ali, “IMATINIB IN CHRONIC MYELOID LEUKEMIA: PATIENT-REPORTED SIDE EFFECTS AND THEIR INFLUENCE ON QUALITY OF LIFE”, PAFMJ, vol. 68, no. 3, pp. 466-70, Oct. 2018.